QPS Delaware expands translational medicine capabilities

08:22 EDT 9 Aug 2017 | CentreWatch

QPS Holdings, a full-service GLP/GCP-compliant CRO providing testing services to support preclinical and clinical research and development, is investing in additional technical personnel and laboratory capacity for translational medicine at its flagship Delaware Technology Park facility. This significant expansion will enable QPS Delaware to process the high sample volumes required for phase III clinical drug […]

The post QPS Delaware expands translational medicine capabilities appeared first on CenterWatch News Online.

Original Article: QPS Delaware expands translational medicine capabilities


More From BioPortfolio on "QPS Delaware expands translational medicine capabilities"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...